In this review, we underscored the importance of further research into the development, testing, and optimization of novel compounds and combination therapies that target the ERK1/2 and PI3K signaling pathways, as this has significant therapeutic potential for cancer patients. This evidence concerns the gene MAPK3 and cancer.